Marpai, Inc. (MRAI) intrinsic value & 10-year financials

Marpai, Inc. (MRAI) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 7 fiscal years revenue shrank 0.3% a year to $18.1M, with an average return on invested capital of -173.1%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$3.13
Market cap
$54.4M
Revenue (FY2025)
$18.1M
Revenue growth (7-yr CAGR)
-0.3%
ROIC (10-yr avg)
-173.1%
Free cash flow (FY2025)
—

MRAI 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $18.1M -$16.6M -$0.95 — -74.9% 242.7%
FY2024 $28.2M -$22.1M -$1.92 — -78.4% -510.0%
FY2023 $37.2M -$28.8M -$4.14 — -75.3% -209.5%
FY2022 $24.3M -$26.5M -$1.31 -$35.6M -110.7% -181.2%
FY2021 $14.2M -$16.0M -$0.80 -$11.1M -111.5% -458.2%
FY2020 $18.4M -$3.9M -$0.20 -$2.0M -18.3% 77.9%
FY2019 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Marpai, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Marpai, Inc. returns on capital have been average, hovering around 11.1% ROIC over the decade.

Marpai, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Marpai, Inc. is modeled at -0.3% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-6.44 per share.

MRAI stock: frequently asked questions

What is the intrinsic value of Marpai, Inc. (MRAI) stock?

Graham's formula only works with positive earnings. Marpai, Inc. reported diluted EPS of -$0.95 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

What is MRAI's return on invested capital?

Average ROIC over the last 7 fiscal years was -173.1%, and average return on equity was 142.8%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this MRAI data come from?

From Marpai, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 15, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar misc health & allied services stocks